SCHEMBL24626264

SCHEMBL24626264

c1ccc(-c2cc(-c3ccccn3)nc(-c3cccc(-c4ccc(-c5ccccc5-c5cc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)n3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.45
▸ LMNA P02545 4/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ TP53 P04637 2/20 0.45
▸ CCR1 P32246 2/20 0.45
▸ CCR5 P51681 2/20 0.45
▸ CCR8 P51685 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ ALPL P05186 1/20 0.45
▸ HSP90AA1 P07900 1/20 0.45
▸ ALPI P09923 1/20 0.45
▸ ALPG P10696 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MEN1 O00255 5/20 0.42
▸ KMT2A Q03164 5/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPT P10636 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24626289 0.96 KDM4E (0.46) KDM4ELMNASMN1; SMN2TP53CCR1
SCHEMBL24626714 0.96 KDM4E (0.46) KDM4ELMNASMN1; SMN2TP53CCR1
SCHEMBL24626707 0.94 KDM4E (0.44) KDM4ELMNASMN1; SMN2TP53CCR1
SCHEMBL24626829 0.94 KDM4E (0.49) KDM4ELMNASMN1; SMN2TP53CCR1
SCHEMBL24626370 0.92 SMN1; SMN2 (0.47) KDM4ELMNASMN1; SMN2TP53CCR1
SCHEMBL24626946 0.92 KDM4E (0.50) KDM4ELMNASMN1; SMN2TP53CCR1
SCHEMBL24626276 0.92 KDM4E (0.53) KDM4ELMNASMN1; SMN2TP53CCR1
SCHEMBL23081971 0.92 KDM4E (0.53) KDM4ELMNASMN1; SMN2TP53CCR1
SCHEMBL24626437 0.92 KDM4E (0.53) KDM4ELMNASMN1; SMN2TP53CCR1
SCHEMBL24626916 0.92 KDM4E (0.53) KDM4ELMNASMN1; SMN2TP53CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223795-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223795-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 KDM4E 2496/4885LMNA 3994/4885SMN1; SMN2 3932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback